S&P 500   4,664.35 (+1.52%)
DOW   35,214.27 (+0.90%)
QQQ   399.18 (+2.04%)
AAPL   160.44 (+2.31%)
MSFT   337.53 (+2.38%)
FB   338.09 (+1.49%)
GOOGL   2,901.46 (+2.03%)
AMZN   3,575.50 (+2.02%)
TSLA   1,130.42 (+4.48%)
NVDA   330.17 (+4.81%)
BABA   132.05 (-0.97%)
NIO   40.06 (+0.18%)
CGC   11.11 (-4.96%)
AMD   158.97 (+2.69%)
GE   97.91 (+0.07%)
MU   85.06 (+1.97%)
T   23.95 (-1.11%)
F   19.77 (+0.10%)
DIS   145.58 (-1.71%)
ACB   6.50 (-4.27%)
AMC   36.53 (-2.92%)
PFE   53.83 (-0.31%)
BA   197.55 (-0.83%)
S&P 500   4,664.35 (+1.52%)
DOW   35,214.27 (+0.90%)
QQQ   399.18 (+2.04%)
AAPL   160.44 (+2.31%)
MSFT   337.53 (+2.38%)
FB   338.09 (+1.49%)
GOOGL   2,901.46 (+2.03%)
AMZN   3,575.50 (+2.02%)
TSLA   1,130.42 (+4.48%)
NVDA   330.17 (+4.81%)
BABA   132.05 (-0.97%)
NIO   40.06 (+0.18%)
CGC   11.11 (-4.96%)
AMD   158.97 (+2.69%)
GE   97.91 (+0.07%)
MU   85.06 (+1.97%)
T   23.95 (-1.11%)
F   19.77 (+0.10%)
DIS   145.58 (-1.71%)
ACB   6.50 (-4.27%)
AMC   36.53 (-2.92%)
PFE   53.83 (-0.31%)
BA   197.55 (-0.83%)
S&P 500   4,664.35 (+1.52%)
DOW   35,214.27 (+0.90%)
QQQ   399.18 (+2.04%)
AAPL   160.44 (+2.31%)
MSFT   337.53 (+2.38%)
FB   338.09 (+1.49%)
GOOGL   2,901.46 (+2.03%)
AMZN   3,575.50 (+2.02%)
TSLA   1,130.42 (+4.48%)
NVDA   330.17 (+4.81%)
BABA   132.05 (-0.97%)
NIO   40.06 (+0.18%)
CGC   11.11 (-4.96%)
AMD   158.97 (+2.69%)
GE   97.91 (+0.07%)
MU   85.06 (+1.97%)
T   23.95 (-1.11%)
F   19.77 (+0.10%)
DIS   145.58 (-1.71%)
ACB   6.50 (-4.27%)
AMC   36.53 (-2.92%)
PFE   53.83 (-0.31%)
BA   197.55 (-0.83%)
S&P 500   4,664.35 (+1.52%)
DOW   35,214.27 (+0.90%)
QQQ   399.18 (+2.04%)
AAPL   160.44 (+2.31%)
MSFT   337.53 (+2.38%)
FB   338.09 (+1.49%)
GOOGL   2,901.46 (+2.03%)
AMZN   3,575.50 (+2.02%)
TSLA   1,130.42 (+4.48%)
NVDA   330.17 (+4.81%)
BABA   132.05 (-0.97%)
NIO   40.06 (+0.18%)
CGC   11.11 (-4.96%)
AMD   158.97 (+2.69%)
GE   97.91 (+0.07%)
MU   85.06 (+1.97%)
T   23.95 (-1.11%)
F   19.77 (+0.10%)
DIS   145.58 (-1.71%)
ACB   6.50 (-4.27%)
AMC   36.53 (-2.92%)
PFE   53.83 (-0.31%)
BA   197.55 (-0.83%)
NASDAQ:BIMI

BOQI International Medical Stock Forecast, Price & News

$0.77
-0.13 (-14.44%)
(As of 11/29/2021 12:16 PM ET)
Add
Compare
Today's Range
$0.77
$0.89
50-Day Range
$0.58
$1.00
52-Week Range
$0.53
$2.81
Volume
95,383 shs
Average Volume
3.04 million shs
Market Capitalization
$28.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.36
30 days | 90 days | 365 days | Advanced Chart
Receive BIMI News and Ratings via Email

Sign-up to receive the latest news and ratings for BOQI International Medical and its competitors with MarketBeat's FREE daily newsletter.


About BOQI International Medical

BIMI International Medical, Inc. engages in the provision of healthcare products. It deals with the retail and wholesale of medical devices, pharmaceuticals, and other relates services. It intends to establish a chain of hospitals specializing in obstetrics and gynecology. The company was founded on October 31, 2000 and is headquartered in Chongqing, China.

Headlines

Is BIMI International Medical a Buy Under $1?
November 2, 2021 |  stocknews.com
See More Headlines

Industry, Sector and Symbol

Industry
Miscellaneous fabricated metal products
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BIMI
Employees
222
Year Founded
N/A

Sales & Book Value

Annual Sales
$12.85 million
Book Value
$0.95 per share

Profitability

Net Income
$-2 million
Pretax Margin
-32.99%

Debt

Price-To-Earnings

Miscellaneous

Free Float
32,823,000
Market Cap
$28.31 million
Optionable
Not Optionable

Company Calendar

Last Earnings
11/15/2021
Today
11/29/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
4/07/2022

MarketRank

Overall MarketRank

1.06 out of 5 stars

Medical Sector

1233rd out of 1,392 stocks

Miscellaneous Fabricated Metal Products Industry

10th out of 13 stocks

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -












BOQI International Medical (NASDAQ:BIMI) Frequently Asked Questions

How has BOQI International Medical's stock price been impacted by Coronavirus?

BOQI International Medical's stock was trading at $3.48 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BIMI shares have decreased by 77.5% and is now trading at $0.7842.
View which stocks have been most impacted by COVID-19
.

Are investors shorting BOQI International Medical?

BOQI International Medical saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 1,620,000 shares, a decrease of 41.5% from the October 31st total of 2,770,000 shares. Based on an average trading volume of 8,160,000 shares, the days-to-cover ratio is currently 0.2 days.
View BOQI International Medical's Short Interest
.

When is BOQI International Medical's next earnings date?

BOQI International Medical is scheduled to release its next quarterly earnings announcement on Thursday, April 7th 2022.
View our earnings forecast for BOQI International Medical
.

How were BOQI International Medical's earnings last quarter?

BOQI International Medical, Inc. (NASDAQ:BIMI) posted its earnings results on Monday, November, 15th. The company reported ($0.06) earnings per share for the quarter. The firm had revenue of $13.78 million for the quarter. BOQI International Medical had a negative net margin of 25.47% and a negative trailing twelve-month return on equity of 39.37%.
View BOQI International Medical's earnings history
.

Who are BOQI International Medical's key executives?

BOQI International Medical's management team includes the following people:
  • Tie Wei Song, President, Chief Executive Officer & Director
  • Xiao Ping Wang, Chief Operating Officer & Director
  • Baiqun Zhong, Chief Financial Officer

Who are some of BOQI International Medical's key competitors?

What other stocks do shareholders of BOQI International Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BOQI International Medical investors own include iBio (IBIO), Airgain (AIRG), AIM ImmunoTech (AIM), Aytu Biopharma (AYTU), Nuwellis (CHFS), Clovis Oncology (CLVS), (COCP), Inovio Pharmaceuticals (INO), Inpixon (INPX) and Lianluo Smart (LLIT).

What is BOQI International Medical's stock symbol?

BOQI International Medical trades on the NASDAQ under the ticker symbol "BIMI."

Who are BOQI International Medical's major shareholders?

BOQI International Medical's stock is owned by many different institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (1.73%), CVI Holdings LLC (1.11%) and Citadel Advisors LLC (0.25%).

Which major investors are buying BOQI International Medical stock?

BIMI stock was acquired by a variety of institutional investors in the last quarter, including CVI Holdings LLC, Renaissance Technologies LLC, and Citadel Advisors LLC.

How do I buy shares of BOQI International Medical?

Shares of BIMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BOQI International Medical's stock price today?

One share of BIMI stock can currently be purchased for approximately $0.78.

How much money does BOQI International Medical make?

BOQI International Medical has a market capitalization of $28.68 million and generates $12.85 million in revenue each year.

How many employees does BOQI International Medical have?

BOQI International Medical employs 222 workers across the globe.

What is BOQI International Medical's official website?

The official website for BOQI International Medical is www.bimihc.com.

Where are BOQI International Medical's headquarters?

How can I contact BOQI International Medical?

BOQI International Medical's mailing address is ROOM 3601 BUILDING A HARBOUR VIEW PL NO 2 WUWU ROAD ZHONGSHAN DISTRICT DALIAN, DALIAN F4, 116000. The company can be reached via phone at 8641182209211, via email at [email protected], or via fax at 86-24-8563-1159.


This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.